Man Group plc - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 323 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Man Group plc ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$312,065
-82.8%
11,319
-81.3%
0.00%
-83.3%
Q2 2023$1,817,488
+26.8%
60,462
+52.8%
0.01%
+20.0%
Q1 2023$1,433,331
-1.4%
39,562
-3.0%
0.01%0.0%
Q4 2022$1,454,087
+410.2%
40,765
+274.0%
0.01%
+400.0%
Q1 2021$285,000
-94.4%
10,900
-94.6%
0.00%
-95.5%
Q4 2020$5,096,000
-3.5%
202,528
-20.1%
0.02%
+4.8%
Q3 2020$5,279,000
+17.8%
253,328
+34.3%
0.02%
-8.7%
Q2 2020$4,481,000
+97.6%
188,673
+49.6%
0.02%
+53.3%
Q1 2020$2,268,000
-18.3%
126,091
+7.8%
0.02%
+66.7%
Q4 2019$2,775,000
+77.8%
117,016
+106.0%
0.01%
+50.0%
Q3 2019$1,561,000
+16.8%
56,791
+40.6%
0.01%
+20.0%
Q2 2019$1,336,000
-72.3%
40,380
-70.6%
0.01%
-72.2%
Q1 2019$4,817,000
+2182.9%
137,457
+2065.4%
0.02%
+1700.0%
Q4 2018$211,000
-96.3%
6,348
-94.4%
0.00%
-95.2%
Q3 2018$5,740,000
-43.0%
114,010
-32.2%
0.02%
-48.8%
Q2 2018$10,063,000
-5.8%
168,152
-27.9%
0.04%
-16.3%
Q1 2018$10,681,000233,2140.05%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders